GC Genome Corporation
KOE: 340450.KQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Medical - Equipment & Services
- CEO
- Chang-Seok Ki
- Employees
- 125
- Headquarters
- Yongin-si, South Korea
- IPO year
- 2025
- Market cap
- ₩175.7B
- Website
- https://www.gcgenome.com
Loading 340450…
Loading profile data…Frequently asked questions about 340450
What does GC Genome Corporation (340450.KQ) do?
GC Genome Corporation operates as a clinical genome analysis company in South Korea. It offers hereditary cancer, tissue and liquid biopsy genetic, blood cancer, and homologous recombination deficiency tests under the Green Plan names; Guardant360, a blood genetic profiling test; Guardant Reveal, a liquid biopsy microscopic residual disease dete...
Where does 340450.KQ trade?
GC Genome Corporation (340450.KQ) trades on the KOSDAQ.
What sector is 340450.KQ in?
GC Genome Corporation (340450.KQ) operates in the Healthcare sector, specifically in the Medical - Equipment & Services industry.
Who is the CEO of GC Genome Corporation?
Chang-Seok Ki is the chief executive officer of GC Genome Corporation (340450.KQ).
Where is GC Genome Corporation headquartered?
GC Genome Corporation is headquartered in South Korea.
Does 340450.KQ pay a dividend?
GC Genome Corporation (340450.KQ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 340450.KQ go public?
GC Genome Corporation (340450.KQ) completed its initial public offering in 2025.